Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Myocardial Ischemia
Interventions
PROCEDURE

Coronary stenting

Within 1h after the first PCI, patients will be randomized to either ticagrelor or clopidogrel.

PROCEDURE

intracoronary ECG recording

Measurement of ST segment elevation using intracoronary ECG recording

PROCEDURE

Coronary Flow reserve

measured with an intracoronary pressure/temperature sensor-tipped guidewire

PROCEDURE

Index of Microcirculatory Resistance

measured with an intracoronary pressure/temperature sensor-tipped guidewire

PROCEDURE

Fractional Flow Reserve

measurement of Fractional Flow Reserve during hyperemic phase.

Trial Locations (1)

00168

Catholic University of the Sacred Heart, Rome

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Italo Porto

OTHER